Literature DB >> 9018082

Reduced glutathione and S-acetylglutathione as selective apoptosis-inducing agents in cancer therapy.

B Donnerstag1, G Ohlenschlager, J Cinatl, M Amrani, D Hofmann, S Flindt, G Treusch, L Träger.   

Abstract

The effect of reduced glutathione (GSH) and S-acetylglutathione (S-acglu) treatment on several tumor cell lines and normal cells in vitro was investigated. GSH and S-acglu applied at concentrations of 1 mM and 2 mM induced apoptosis in malignant cells as shown by DNA-fragmentation and staining of apoptotic cells with 7-amino-actinomycin D while viability and growth of normal cells were not significantly influenced by this treatment. The results demonstrated that GSH and S-acglu may be selective inducers of apoptosis in malignant cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9018082     DOI: 10.1016/s0304-3835(96)04461-8

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  4 in total

1.  Epigallocatechin-3-gallate regulates cell growth, cell cycle and phosphorylated nuclear factor-κB in human dermal fibroblasts.

Authors:  Dong-wook Han; Mi Hee Lee; Hak Hee Kim; Suong-hyu Hyon; Jong-chul Park
Journal:  Acta Pharmacol Sin       Date:  2011-04-25       Impact factor: 6.150

2.  HO-3867, a safe STAT3 inhibitor, is selectively cytotoxic to ovarian cancer.

Authors:  Kellie S Rath; Shan K Naidu; Pushpa Lata; Hemant K Bid; Brian K Rivera; Georgia A McCann; Brent J Tierney; Adam C Elnaggar; Veronica Bravo; Gustavo Leone; Peter Houghton; Kálmán Hideg; Periannan Kuppusamy; David E Cohn; Karuppaiyah Selvendiran
Journal:  Cancer Res       Date:  2014-03-03       Impact factor: 12.701

3.  Apoptotic Activities of Sanguinaria canadensis: Primary Human Keratinocytes, C-33A, and Human Papillomavirus HeLa Cervical Cancer Lines.

Authors:  Cynthia Ann Leaver; Hang Yuan; Gwenyth R Wallen
Journal:  Integr Med (Encinitas)       Date:  2018-02

4.  Cisplatin, glutathione and the third wheel: a copper-(1,10-phenanthroline) complex modulates cisplatin-GSH interactions from antagonism to synergism in cancer cells resistant to cisplatin.

Authors:  Sarah Vascellari; Elisa Valletta; Daniela Perra; Elisabetta Pinna; Alessandra Serra; Francesco Isaia; Alessandra Pani; Tiziana Pivetta
Journal:  RSC Adv       Date:  2019-02-12       Impact factor: 4.036

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.